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Connexins are integral membrane proteins forming aqueous gap junction channels that allow the diffusional
exchange of ions and small metabolites between cells, thus coordinating metabolic activities in multicellular
tissues. Dominant mutations in the Cx26 gene GJB2 have been shown to cause keratitis-ichthyosis-deafness (KID)
syndrome, palmoplantar keratoderma associated with hearing loss, and Vohwinkel syndrome. Missense mutations
in the closely related Cx30 gene GJB6 underlie Clouston syndrome (autosomal dominant hidrotic ectodermal
dysplasia). We report a 6-y-old boy with phenotypic characteristics of KID syndrome as well as atrichia. In contrast
to other KID syndrome patients, molecular analysis of the connexin gene GJB2 did not disclose a pathogenic
mutation, although the patient was homozygous for a common polymorphism (V27I) in the coding sequence of
Cx26. Nevertheless, screening of GJB6 revealed a heterozygous missense mutation (V37E) predicted to alter
sequence and charge of the ﬁrst transmembrane helix of Cx30, which was previously implicated in Clouston
syndrome (Smith et al, 2002). The presence of a pathogenic Cx30 mutation and the lack of a pathologic molecular
change in Cx26 in this patient, whose clinical features predominantly resemble KID syndrome, suggest genetic
heterogeneity of KID syndrome and underscore that mutations in Cx30, similar to those in Cx26 or Cx31, can cause
different phenotypes. Based on our results, connexin gene mutations should be considered in patients presenting
with congenital sensorineural hearing loss and disorders of corniﬁcation, and screening of several connexin genes
with known cutaneous phenotype, such as those for Cx26, Cx30, Cx30.3, and Cx31, may be required.
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Keratitis-ichthyosis-deafness (KID) syndrome (OMIM
148210) and Clouston syndrome (hidrotic ectodermal
dysplasia; OMIM 129500) are rare autosomal dominant
ectodermal dysplasias due to germline mutations in the
connexin genes GJB2 and GJB6, respectively, which cluster
at chromosome 13q11 and encode the closely related gap
junction proteins Cx26 and Cx30 (Lamartine et al, 2000;
Richard et al, 2002; van Steensel et al, 2002). KID and
Clouston syndrome share a few overlapping features, such
as nail dystrophy, hair loss, and palmoplantar keratoderma.
Although the disorders are usually readily distinguishable on
clinical grounds in patients with a full-blown picture, the
differentiation can be challenging in others.
KID syndrome is a rare, mostly sporadic disorder with a
broad spectrum of cutaneous features, including erythro-
keratoderma, follicular hyperkeratoses, psoriasiform or
verrucous plaques, acanthosis, and palmoplantar kerato-
derma (PPK) often described as reticulated or pitted
(reviewed in Caceres-Rios et al, 1996; Sundaram et al,
2003). Between 90% and 93% of affected individuals have
prelingual sensorineural hearing loss (SNHL) (Caceres-Rios
et al, 1996; Sundaram et al, 2003), which is often bilateral
and severe to profound (Sybert, 1997; Szymko-Bennett et al,
2002). Corneal symptoms often manifest during childhood
with photophobia, punctate keratitis, and progressive
corneal vascularization that may later result in visual decline
and blindness (Caceres-Rios et al, 1996). Many KID
syndrome patients were reported to have sparse or
lusterless hair, but only approximately 10%–23% have
congenital absence of hair (Caceres-Rios et al, 1996;
Sundaram et al, 2003). Other findings that are variably
present include nail dystrophy, dental anomalies, hypohi-
drosis, growth delay, increased susceptibility to cutaneous
infections, and a propensity for developing squamous cell
carcinomas (Caceres-Rios et al, 1996). KID syndrome is
caused by autosomal dominant missense mutations in the
connexin gene GJB2. A common mutation that has been
reported in 12 of 15 unrelated patients tested results in the
replacement of aspartic acid 50 with asparagine (D50N) in
the first extracellular loop of Cx26 (Richard et al, 2002; van
Geel et al, 2002; van Steensel et al, 2002; Alvarez et al,
2003; Yotsumoto et al, 2003). This sequence motif is high-
ly conserved among all connexins and any change in
composition and charge is likely detrimental for the
formation and function of gap junction channels (Rubin
et al, 1992; White et al, 1995). Other mutations cluster in the
intracellular amino terminus of this gap junction protein
(Richard et al, 2002).
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Clouston syndrome is an autosomal dominant ectoder-
mal dysplasia particularly common among the French–
Canadian population due to a founder effect (Lamartine et al,
2000). The principal features include nail dystrophy, hair
loss, and PPK. Nail abnormalities are usually present in all
patients and may range from almost normal appearing nails
to micro- or anonychia (Clouston, 1929). Nail plate changes
may include thickening, brittleness, discoloration, splitting,
and onycholysis (Clouston, 1929; Clouston, 1939; Rajago-
palan and Tay, 1977; Hassed et al, 1996). Paronychia and
nail infections are common (Clouston, 1929; Kibar et al,
1996). Hair abnormalities manifest at birth or later as atrichia
or hypotrichosis with brittle, slow-growing hair, and may be
progressive. Some but not all patients develop diffuse PPK
and discrete hyperpigmentations over joints, whereas
strabismus and cataracts are rare (Clouston, 1929; Clous-
ton, 1939; Hazen, 1980). Sweat function and teeth are
normal (Rajagopalan and Tay, 1977; Hassed et al, 1996;
Sybert, 1997). Unlike in KID syndrome, patients with
Clouston syndrome lack vascularizing keratitis and SNHL.
The latter has only been described in families with
autosomal recessive onychodystrophy (Feinmesser and
Zelig, 1961) or autosomal dominant onychodystrophy with
additional abnormalities (conical teeth, hypodontia, syn-
dactyly, and polydactyly) without PPK and hair involvement,
suggestive of a distinct syndrome (see OMIM 124480)
(Robinson et al, 1962). Lamartine et al (2000) identified two
different missense mutations in the Cx30 gene, G11R and
A88V, each of which segregated with Clouston syndrome in
12 families of French–Canadian and other backgrounds. In
addition, a de novo mutation in the first transmembrane
domain of Cx30, V37E, has been detected in a patient with
sporadic Clouston syndrome (Smith et al, 2002).
Here, we report a young boy with features of KID
syndrome and congenital atrichia, who was found to carry a
deleterious missense mutation in the Cx30 gene (GJB6).
Our findings expand the phenotypic spectrum of mutations
in GJB6, and further underscore the overlapping nature of
syndromes thus far attributed to the four connexins with
cutaneous manifestations.
Results
Clinical features The proband is a 6-y-old boy born to
non-consanguineous, unaffected parents after an unevent-
ful pregnancy. The maternal family history did not reveal
evidence for hearing impairment or ectodermal dysplasia.
The paternal family history could not be obtained. Since
birth, he has had dry, leathery skin; short and thickened
dystrophic nails; no scalp hair, eyebrows and eyelashes;
and severe photophobia. His sweating has been impaired,
which was confirmed with a bromophenol test at 6.5 mo of
age. In early childhood, his growth and weight remained
below the 5th percentile and his motor development was
slightly delayed. In recent years, he has caught up to the
5th-10th percentile for these growth parameters. Audio-
logical testing revealed prelingual bilateral mild to moderate
SNHL but his speech has improved significantly with the
use of hearing aids since the age of 5 y. Mild keratitis and
corneal vascularization were evident on ophthalmologic
examination at the age of 5 y.
At 6.5 mo of age, dermatological examination revealed
generalized erythema and thickened skin with a cobble-
stone appearance, sparing only the diaper area. In addition,
a verrucous, hyperkeratotic plaque on his left antecubital
fossa was noted. Six years later (Fig 1), the patient’s skin
continued to show slight erythroderma and was covered
with innumerable spiny papules with accentuation on the
posterior neck, lower back, knees, and elbows. Only the
glans penis and sandal strap regions of the dorsal feet were
spared. He also had diffuse PPK with a cobblestone or
ceribriform surface. In addition, a few scattered, verrucous,
and fissured papules up to 10 mm in diameter were noted in
the perineal area. The patient had complete absence of
body and scalp hair, eyebrows, and eyelashes. He had mild
conjunctival injection and corneal neovascularization, but
no blepharitis, ectropion, eyelid adhesions, or nystagmus.
His primary teeth were normal in number and shape,
although he had a few dental cavities. The oral mucosa was
unremarkable. Several of his fingernails had been shed, and
the remaining ones, similar to the toenails, were thickened,
short, and demonstrated distal onycholysis. He had mild
heat intolerance during the summer months. The past
medical history also revealed recurrent episodes of nail
infections as well as an unrelated peanut allergy.
Histology At 6.5 mo of age, a skin biopsy of the patient’s
left posterior arm revealed an abundance of eccrine sweat
glands and ducts, which could be age-related, whereas
only a few small, abortive hair follicles without hair shafts
were identified (Fig 1). The ostia of appendages showed
dilatation and plugging with orthokeratotic hyperkeratosis
and a prominent granular layer. Sebaceous glands were
present.
Mutation analysis reveals a heterozygous missense
mutation in GJB6 (Cx30) The presence of all key features
of KID-syndrome prompted initial mutation analysis of the
GJB2 (Cx26) gene. The proband was found to be homo-
zygous for a G to A transition at nucleotide 79 (from ATG
start site) in codon 27, changing a hydrophobic residue,
valine (GTC), with another, isoleucine (ATC) (V27I). This
substitution, also found in unaffected controls in homo-
zygous or heterozygous state, represents a common
polymorphism with a frequency of the minor (A) allele of
0.005–0.52 in different populations (Kelley et al, 1998; Abe
et al, 2000; Kudo et al, 2000; Park et al, 2000). In our
Northern European control cohort (156 chromosomes), the
allele frequency was 0.013. Since no other sequence
variants were detected in GJB2, the connexin genes GJB6
as well as GJB3, GJB4, GJB5, and GJA1 were scrutinized.
The proband harbored a heterozygous 110T ! A transver-
sion in GJB6, which was not present in his mother’s DNA
sample (Fig 2). His father was unavailable for testing. This
point mutation is predicted to lead to a non-conservative
replacement of valine 37 (GTG) with a negatively charged
glutamic acid (GAG) (V37E) in the first transmembrane helix
of Cx30. The nucleotide change was not detected in a
cohort of 50 unrelated individuals of Northern European
origin without genodermatoses or hearing loss, nor in the
additional 100 Northern European controls published pre-
viously (Smith et al, 2002), excluding the possibility that
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V37E represents a non-consequential sequence poly-
morphism. No sequence aberrations were found in four
other connexin genes expressed in stratifying epithelia of
ectodermal origin, including GJB3, GJB4, GJB5, and GJA1.
Discussion
Connexins are a large family of small integral membrane
proteins utilized by most vertebrate tissues to establish
direct cell–cell communication through gap junction chan-
nels. Similar to certain other adhesion molecules, such as
claudins, occludin, or PMP22, they contain four hydro-
phobic domains transversing the plasma membrane (M1–
M4, Fig 2). These a-helices separate 2 highly conserved
hydrophilic loops extending into the extracellular space
from 3 relatively variable cytoplasmic domains. Six con-
nexin molecules oligomerize into homomeric or heteromeric
connexin hemichannels, which are integrated into the
plasma membrane where they may accumulate to gap
junction plaques and associate with their counterparts in
adjacent cells to complete intercellular channels. These
channels permit the diffusion of small molecules (up to  1
kDa) between cells and mediate the exchange of signals
and nutrients, thereby coordinating cellular activities and
response to stimuli. In the skin, up to 10 different connexin
molecules have been detected, which are expressed in
spatial and temporal overlapping patterns, and are partially
shared by other stratified epithelia (Richard, 2000a; Di et al,
2001). Despite the apparent redundancy of the gap junction
system, each connexin appears to have specific properties,
which is illustrated by the fact that inherited defects in
several connexin genes result in related yet distinct skin
disorders, including PPK associated with SNHL, Vohwinkel
syndrome and KID syndrome (GJB2), Clouston syndrome
(GJB6), and erythrokeratodermia variabilis (GJB3 and
GJB4) (Richard, 2003a).
We report a patient with an unusual clinical presentation
resulting in diagnostic difficulties. He presented with a
combination of clinical features characteristic of KID
syndrome, including congenital bilateral SNHL, keratitis,
and mild erythroderma. In addition, he had congenital
absence of hair, PPK, and nail dystrophy, which are also
seen in Clouston syndrome, and generalized spiny hyper-
keratotic papules as described in HID syndrome (Hystrix-
like Ichthyosis Deafness syndrome) (Traupe, 1989). In
contrast to all other KID and HID syndrome, patients
harboring pathogenic mutations in GJB2 (Richard et al,
2002; van Geel et al, 2002; van Steensel et al, 2002), our
molecular studies revealed a heterozygous mutation in
GJB6. The identified mutation V37E in GJB6 was recently
observed in a patient with Clouston syndrome without
evidence for abnormal sweating, hearing, photophobia, and
keratitis (Smith et al, 2002). These findings illustrate a
perplexing phenotypic variability of the GJB6 mutation V37E
and underscore the profound influence of genetic and
epigenetic factors that modify the clinical phenotype. In
fact, other GJB6 mutations originally described in patients
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Figure 1
Clinical features and histopathology. Six-y–old boy with atrichia of the scalp, eyebrows and eyelashes, generalized mild erythroderma and
spiculate, hyperkeratotic papules, here shown on the face (A–C). Note that each tiny white dot represents a filiform hyperkeratosis. Diffuse plantar
keratoderma (D) with rough, cobblestone-like surface (D, F) and nail dystrophy with short, thickened nail plates (E). Light microscopy (H/E) of a skin
biopsy at 6.5 mo of age (H) revealed paucity of hair follicles, dilatation, and orthokeratotic plugging of appendageal ostia (see close-up in (I)) in
contrast to a biopsy from a 5 mo-old patient with congenital ichthyosis (G).
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with Clouston syndrome, such as G11R and A88V, may also
result in forme fruste with hypertrophic nail dystrophy
closely resembling pachyonychia congenita, alone or in
combination with hypotrichosis (Van Steensel et al, 2003). In
contrast, mutation T5M has been associated with SNHL
without any other associated features (Grifa et al, 1999). It is
tempting to speculate that the unique disorder of the patient
studied here might be related, at least in part, to the
presence of a homozygous sequence polymorphism in
GJB2 replacing valine27 with isoleucine. Despite detailed
functional analyses of numerous recessive and dominant
Cx26 mutations, the functional properties of this particular
polymorphic variant of Cx26 remain unknown. Other Cx26
mutations that were originally considered non-consequen-
tial polymorphisms, such as M34T and V37I (orthologous to
the GJB6 mutation reported here), were subsequently found
to represent recessive alleles with reduced or absent
channel permeability (Bruzzone et al, 2003; Oshima et al,
2003). Hence, it will be interesting to learn if V27I-Cx26 has
consequences on Cx26 function and, perhaps, on assembly
or channel properties of mixed channels formed with wild-
type Cx30 or mutant V37E-Cx30, which could aggravate the
pathological processes.
Our findings demonstrate for the first time that KID
syndrome is genetically heterogeneous and caused by
mutations in either GJB2 or GJB6. Therefore, KID syndrome
is another example of a connexin disorder attributable to
mutations in more than one connexin gene, as are EKV
(GJB3, GJB4), non-syndromic SNHL (GJB2, GJB6, GJB3),
or cataract (GJA3, GJA8). Although dominant Cx26 muta-
tions in KID syndrome either affect a hypermutable CpG
dinucleotide in the first extracellular domain or cluster in the
N-terminus, the mutation identified here, V37E, lies in the
first transmembrane helix of Cx30. Based on a 3-dimen-
sional map of truncated Cx43 (Unger et al, 1999) as well as
SCAM (scanning cysteine accessibility mutagenesis) analy-
sis of Cx32 (Zhou et al, 1997), this domain has been shown
to line the cytoplasmic end of the channel pore and is part
of a voltage sensing and transduction mechanism. Conse-
quently, ion selectivity and other channel properties critically
depend on the sequence, charge, and side chain conserva-
tion of this domain. Replacing this hydrophobic valine in
GTG (Val37)
GAG (Glu37)
Wildtype sequence
Human Cx26        RIMIL       V    VAAKE
Mouse  Cx26        RIMIL       V    VAAKE
Human Cx30        RVMIL      V    VAAQE
Mouse  Cx30        RVMIL      V    VAAQE
Human Cx30.3     RVLVY     V    VAAEE
Mouse  Cx30.3     RVLVY     V    VAAEE
Human Cx31        RVLVY     V    VAAER
Mouse  Cx31        RVLVY     V    VAAER
Human Cx32        RIMVL      V    VAAES
Mouse  Cx32        RIMVL      V    VAAES
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Figure 2
Mutation analysis. (A) Compared with the wild-type sequence (upper chromatogram), mutation analysis in the patient demonstrated a
heterozygous T to A transversion, resulting in the substitution of valine with glutamic acid (V37E) (lower chromatogram). (B) dHPLC analysis of Cx30
PCR amplicons encompassing the mutation site revealed heteroduplex formation in the patient sample (double peak, lower panel), which is not
present in his unaffected mother (single peak, upper panel) and unaffected controls. (C) Sequence alignment of multiple human and rodent
connexins demonstrated a strong conservation of the valine residue at this position in the first transmembrane domain. (D) Schematic representation
of Cx30 depicting the predicted structural motifs and the position of pathogenic mutations with cutaneous manifestation (arrows). NT: cytoplasmic
amino-terminus; M1–M4: transmembrane domains; E1, E2: extracellular domains; CL: cytoplasmic loop; CT: cytoplasmic carboxy-terminus.
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Cx30 with a charged oglutamate acid residue can be
expected to disrupt the alpha-helical structure of this
transmembrane domain and ultimately alter the assembly
and function of Cx30 in our patient. This prediction is
supported by an in vitro expression study of V37E-Cx30 in
HeLa and NEB1 keratinocytes, in which the mutant protein
was synthesized but failed to be transported to the cell
membranes and therefore could not produce gap junction
plaques (Common et al, 2002). These results are similar to
those obtained for Cx26 mutations causing PPK/SNHL
(Marziano et al, 2003) and KID syndrome (Yi, 2003) as well
as mutations in other connexin genes with a cutaneous
phenotype (Di et al, 2002; Rouan et al, 2003). Whereas the
assembly and trafficking defect observed for several Cx26
mutants could be overcome by co-expression with wtCx26
or wtCx30, the presence of mutant Cx26 subunits in gap
junction plaques was shown to inhibit dominantly the
function of homotypic or mixed gap junction channels, thus
disturbing normal intercellular communication (Marziano
et al, 2003). These data have important implications for
understanding the pathomechanisms of KID syndrome and
provide strong experimental evidence for the existence of
mixed (heterotypic/heteromeric) Cx26/Cx30 gap junctions
in the non-sensory epithelia of the inner ear, where loss of
either protein results in SNHL (Cohen-Salmon et al, 2002;
Kudo et al, 2003; Teubner et al, 2003). Both Cx26 and Cx30
are closely related proteins with 76% amino acid identity
and are also co-expressed in human corneal epithelium as
well as in sweat glands, sweat ducts, and hair follicles
(Richard et al, 2002; Coutinho et al, 2003). In contrast to
Cx30, which is prevalent in the upper differentiated layers of
interfollicular epidermis, Cx26 is only expressed at low
levels in palmoplantar epidermis but is strongly induced in
response to wounding or other trauma (Lucke et al, 1999;
Coutinho et al, 2003). Together with our molecular findings,
this overlapping but not identical tissue expression of Cx26
and Cx30 implies some common functions and perhaps
direct interaction of both proteins in many ectodermal
epithelia, and may form the basis for the observed
pleiotropism of GJB2 and GJB6 mutations, which can
result in SNHL, skin, hair, nail, or corneal pathology alone or
in combination (Richard, 2003a). The prominent hair
phenotype of GJB6 mutations points to a hitherto unex-
plored role of Cx30 in keratinization of hair follicles.
In summary, our data illustrate the increasing complexity
and overlap between cutaneous connexin disorders. The
same Cx30 gene mutation may account for Clouston
syndrome or KID syndrome, which makes it difficult to
draw clinical and prognostic predictions, such as ocular or
audiologic involvement, based on the underlying mutation
alone. Moreover, KID syndrome results from pleiotropic
mutations in 2 different yet closely related connexin genes
that impair the function of the inner ear, cornea, skin, and
appendages with significant variability of the resulting
phenotype. The shared tissue expression and function of
cutaneous connexins may serve as a basis for the broad
clinical overlap observed among the genetic disorders
resulting from alterations in these gap junction proteins.
Based on our results, we suggest considering connexin
gene mutations in any patient with a congenital disorder of
cornification with or without erythema associated with SNHL
or involvement of other ectodermal tissues, whereby muta-
tion analysis should include all genes with potential cuta-
neous phenotype, including Cx26, Cx30, Cx30.3, and Cx31.
Materials and Methods
Patients and biological materials A 6-y-old boy and his
unaffected mother were ascertained and gave written informed
consent to participate in genetic research studies approved by the
institutional review board of Thomas Jefferson University, Phila-
delphia, PA. DNA samples of both individuals were obtained from
buccal mucosa cells (Richards et al, 1993). A paraffin-embedded
3-mm punch biopsy of lesional skin from the left arm of the 6.5-mo-
old proband was analyzed by light microscopy (H/E).
DNA ampliﬁcation and mutation analysis DNA samples were
amplified by PCR for direct DNA sequence analysis of the coding
regions of GJB6, GJB2, GJB3, and GJB4. Primer sequences were
derived from the genomic gene sequences (GenBank accession
numbers: AJ005585; NT_009799 [GJB6]; U43932; M86849;
NT_009799 [GJB2]; AF099730; AL121988 [GJB3]; AL121988
[GJB4]; AF099731 [GJB5]; NT_033944.2 [GJA1]) and are listed as
follows: [GJB6]: (sense) 50-AGAATGCTTTCAGGGTGGG-30 (nu-
cleotides –196 to –178 from ATG translation start site) and (anti-
sense) 50-GATTCGGAAAAAGATGCTGC-30 (nucleotides 413 to
432) as well as (sense) 50-GGCCTACTACAGGCACGAAA- 0(nucleo-
85 to 304) and (antisense) 50-GGTTGGTATTGCCTTCTGGA-30
(nucleotides 835-854); [GJB2]: (sense) 50-GTTCTGTCTTCACCTG-
30 (nucleotides 172 to 157) and (antisense) 50-GGTTGGTAT
TGCCTTCTGG-30(nucleotides 835 to 853), and [GJB5]: (sense) 50-
TCAGCTCCC TCCCTCTACAA-30 (nucleotides 177 to 153) and
(antisense) 50-ATGGCTTAGCTCCCCACTCT-30(nucleotides 896 to
917). PCR reactions were performed using 200 ng genomic DNA,
2.5 IU Taq DNA polymerase, 10% Q-solution (Qiagen, Valencia,
CA), and standard PCR conditions for 60 mL total volume. PCR
cycling conditions were 941C for 2 min; 36 cycles of 941C for 30 s;
571C [GJB6]/561C [GJB2; GJB5] for 45 s; 721C for 60 s; and finally
721C for 7 min. Amplicons were gel purified (QIAquick gel
extraction kit, Qiagen) and directly sequenced using the BigDye
terminator sequencing system on an ABI Prism 377 sequencer (PE
Applied Biosystems, Foster City, CA). Primers and PCR conditions
for amplification and sequencing of GJB3, GJB4, and GJA1 were
used as previously published (Richard et al, 2000b; Paznekas et al,
2002; Richard et al, 2003b). Sequence variants were confirmed by
bi-directional DNA sequencing and in case of mutation 110T ! A
by denaturing high performance liquid chromatography (dHPLC).
This method was also used to exclude the mutation from 100
population-matched control chromosomes. For dHPLC analysis, a
321 bp fragment of GJB6 was PCR-amplified from genomic DNA
with primers (sense) 50-GACGCTGCACACTTTCATC-30 and (anti-
sense) 50- AGTTCAGGCGAGGAGAGAA-30. Each sample was
denatured at 941C for 10 min, cooled to 651C for 10 min to allow
heteroduplex formation, and maintained on ice until loading. Ten
micro liter of each sample was separately injected and analyzed on
a WAVEt DNA fragment analysis system (Transgenomic, Omaha,
NE), over 7.5 min at a temperature gradient of 621C that was
established with the WAVE Maker program 3.4 (Transgenomic).
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